Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Expression of DDR1 and DVL1 in Invasive Ductal and Lobular Breast Carcinoma does not Correlate with Histological Type, Grade and Hormone Receptor Status

  • Ameli, Fereshteh (Department of Pathology, Faculty of Medicine, Universiti Kebangsaan Malaysia) ;
  • Rose, Isa Mohd (Department of Pathology, Faculty of Medicine, Universiti Kebangsaan Malaysia) ;
  • Masir, Noraidah (Department of Pathology, Faculty of Medicine, Universiti Kebangsaan Malaysia)
  • Published : 2015.04.03
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Invasive ductal (IDC) and lobular (ILC) carcinomas are the common histological types of breast carcinoma which are difficult to distinguish when poorly differentiated. Discoidin domain receptor (DDR1) and Drosophila dishevelled protein (DVL1) were recently suggested to differentiate IDC from ILC. Objectives: To assess the expression of DDR1 and DVL1 and their association with histological type, grading and hormonal status of IDC and ILC. Materials and Methods: This cross sectional study was conducted on IDC and ILC breast tumours. Tumours were immunohistochemically stained for (DDR1) and (DVL1) as well as estrogen receptor (ER), progesterone receptor (PR) and C-erbB2 receptor. Demographic data including age and ethnicity were obtained from patient records. Results: A total of 51 cases (30 IDCs and 21 ILCs) were assessed. DDR1 and DVL1 expression was not significantly associated with histological type (p=0.57 and p=0.66 respectively). There was no association between DDR1 and DVL1 expression and tumour grade (p=0.32 and p=1.00 respectively), ER (p=0.62 and 0.50 respectively), PR (p=0.38 and p=0.63 respectively) and C-erbB2 expression (p=0.19 and p=0.33 respectively) in IDC. There was no association between DDR1 and DVL1 expression and tumour grade (p=0.52 and p=0.33 respectively), ER (p=0.06 and p=0.76 respectively), PR (p=0.61 and p=0.43 respectively) and C-erbB2 expression (p=0.58 and p=0.76 respectively) in ILC. Conclusions: This study revealed that DDR1 and DVL1 are present in both IDC and ILC regardless of the tumour differentiation. More studies are needed to assess the potential of these two proteins in distinguishing IDC from ILC in breast tumours.

Keywords

References

  1. Abdullah NA, Wan Mahiyuddin WR, Muhammad NA, et al (2013). Survival rate of breast cancer patients in Malaysia: a population based study. Asian Pac J Cancer Prev, 14, 4591-4. https://doi.org/10.7314/APJCP.2013.14.8.4591
  2. Alsanabani JA, Gallan W, Saadi AA (2015). Incidence data for breast cancer among Yemeni female patients with palpable breast lumps. Asian Pac J Cancer Prev, 16, 191-4. https://doi.org/10.7314/APJCP.2015.16.1.191
  3. Band V, Zhao X, Malhotra G, et al (2011).Shared signaling pathways in normal and breast cancer stem cells. J Carcinogenesis, 10, 38. https://doi.org/10.4103/1477-3163.91413
  4. BhooPathy N, Yip CH, Taib NA, et al (2011). Breast cancer in a multi-ethnic Asian setting: Results from the Singapore-Malaysia hospital-based breast cancer registry. Breast, 20, 75-80.
  5. Bray F, JemalA, Grey N, et al (2012). Global cancer transitions according to the human development index (2008-2030): a population-based study. Lancet Oncology, 13, 790-801. https://doi.org/10.1016/S1470-2045(12)70211-5
  6. DeSantis C, Ma J, Bryan L, et al (2014). Breast cancer statistics, 2013. CA-Cancer J Clin, 64, 52-62. https://doi.org/10.3322/caac.21203
  7. Dey N, Barwick BG, Moreno CS, et al (2013a).Wnt signaling in triple negative breast cancer is associated with metastasis. BMC Cancer, 13, 537. https://doi.org/10.1186/1471-2407-13-537
  8. Dey N, Young B, Abramovitz M, et al (2013b). Differential activation of Wnt-$\beta$-Catenin pathway in triple negative breast cancer increases MMP7 in a PTEN dependent manner. PLoS ONE, 8, 77425. https://doi.org/10.1371/journal.pone.0077425
  9. FeldmanAL,Eunhee SY (2012). Rosai and ackerman's surgical pathology. JAMA, 307, 201-2.
  10. Ferrero-Pous M, Trassard M, Le Doussal V, et al (2001). Comparison of enzyme immunoassay and immunohistochemical measurements of estrogen and progesterone receptors in breast cancer patients.Appl Immunohisto Mol Morph, 9, 267-75.
  11. Figueroa JD, Pfeiffer RM, Patel DA, et al (2014). Terminal duct lobular unit involution of the normal breast: implications for breast cancer etiology. J Natl Cancer Inst, 106, 286. https://doi.org/10.1093/jnci/dju286
  12. Hanley KZ (2014). Rosen's Breast Pathology. LWW.
  13. HussainM,Cunnick GH (2011). Management of lobular carcinoma in-situ and atypical lobular hyperplasia of the breast--a review. Eur J Surg Oncol, 37, 279-89. https://doi.org/10.1016/j.ejso.2011.01.009
  14. Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA-Cancer J Clin, 61, 69-90. https://doi.org/10.3322/caac.20107
  15. Kafka A, Basic-KindaS, Pecina-Slaus N (2014). The cellular story of dishevelleds. Croatian Med J, 55, 459-67. https://doi.org/10.3325/cmj.2014.55.459
  16. Keller PJ, Arendt LM, Skibinski A, et al (2012). Defining the cellular precursors to human breast cancer. Proc Natl Acad Sci USA, 109, 2772-7. https://doi.org/10.1073/pnas.1017626108
  17. Lehr HA, Folpe A, Yaziji H, et al (2000). Cytokeratin 8 immunostaining pattern and E-cadherinexpression distinguish lobular from ductal breast carcinoma. Am J Clin Pathol, 114, 190-6. https://doi.org/10.1309/CPUX-KWEH-7B26-YE19
  18. Majeed W, Aslam B, Javed I, et al (2014). Breast cancer: major risk factors and recent developments in treatment. Asian Pac J Cancer Prev, 15, 3353-8. https://doi.org/10.7314/APJCP.2014.15.8.3353
  19. Man Y, Izadjoo M, Song G, et al (2011). In situ malignant transformation and progenitor-mediated cell budding: two different pathways for breast ductal and lobular tumor invasion. Cancer, 2, 401-12.
  20. Moriya T, Kozuka Y, Kanomata N, et al (2009).The role of immunohistochemistry in the differential diagnosis of breast lesions. Pathology, 41, 68-76.
  21. OmarZA,Tamin NSI (2011). National cancer registry report: malaysia cancer statistics-data and figure 2007. national cancer registry, Ministry of Health Malaysia.
  22. Quan J, Yahata T, Adachi S, et al (2011). Identification of receptor tyrosine kinase, discoidin domain receptor 1 (DDR1), as a potential biomarker for serous ovarian cancer. Intern J Mol Sci, 12, 971-82. https://doi.org/10.3390/ijms12020971
  23. Rocha R, Nunes C, Rocha G, et al (2008). Rabbit monoclonal antibodies show higher sensitivity than mouse monoclonals for estrogen and progesterone receptor evaluation in breast cancer by immunohistochemistry. Pathol Res Pract, 204, 655-62. https://doi.org/10.1016/j.prp.2008.03.010
  24. Russo J, Lynch H, Russo IH (2001). Mammary gland architecture as a determining factor in the susceptibility of the human breast to cancer. Breast, 7, 278-91. https://doi.org/10.1046/j.1524-4741.2001.21033.x
  25. Tiede B, Kang Y (2011). From milk to malignancy: the role of mammary stem cells in development, pregnancy and breast cancer. Cell Res, 21, 245-57. https://doi.org/10.1038/cr.2011.11
  26. Turashvili G, Bouchal J, Baumforth K, et al (2007). Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis. BMC Cancer, 7, 55. https://doi.org/10.1186/1471-2407-7-55
  27. Vaurghese AA, Poothiode U, Manjula V (2015). Descriptive study on selected risk factors and histopathology of breast carcinoma in tertiary care centre in Kerala, India with special reference to women uder 40 years old. Asian Pac J Cancer Prev, 16, 181-4. https://doi.org/10.7314/APJCP.2015.16.1.181
  28. Yeh YC, Wu CC, Wang YK, et al (2011). DDR1 triggers epithelial cell differentiation by promoting cell adhesion through stabilization of E-cadherin. MolBiol Cell, 22, 940-53.
  29. Yin HF, Li T, Zhang H, et al (2009). Differential diagnosis of invasive ductal carcinoma versus invasive lobular carcinoma of breast. Chinese J Pathol, 38, 663-7.
  30. Yoder BJ, Wilkinson EJ, Massoll NA (2007). Molecular and morphologic distinctions between infiltrating ductal and lobular carcinoma of the breast. Breast, 13, 172-9. https://doi.org/10.1111/j.1524-4741.2007.00393.x